The carboxyl segment of the mumps virus V protein associates with stat proteins in vitro via a tryptophan-rich motif

Virology

Volumn 300, Issue 1, 2002, Pages 92-99

  Nishio, Machiko ^a   Garcin, Dominique ^a   Simonet, Viviane ^a   Kolakofsky, Daniel ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYL GROUP; PROTEIN C; STAT PROTEIN; TRYPTOPHAN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN V; ZINC ION;

ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; EXTRACTION; MUMPS VIRUS; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN INTERACTION; PROTEIN MOTIF;

MUMPS VIRUS; PARAMYXOVIRINAE; RUBULAVIRUS;

EID: 0036382729     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1509     Document Type: Article

References (45)

1. Boeck, R., Curran, J., Matsuoka, Y., Compans, R. W., and Kolakofsky, D. (1992). The parainfluenza virus type 1 P/C gene uses a very efficient GUG codon to start its C' protein. J. Virol. 66, 1765-1768.
2. Bromberg, J. F. (2001). Activation of STAT proteins and growth control. Bioessays 23, 161-169.
3. Buchholz, U. J., Finke, S., and Conzelmann, K. K. (1999). Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73, 251-259.
4. Cattaneo, R., Kaelin, K., Baczko, K., and Billeter, M. A. (1989). Measles virus editing provides an additional cysteine-rich protein. Cell 56, 759-764.
5. Curran, J., Boeck, R., and Kolakofsky, D. (1991). The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J. 10, 3079-3085.
6. Curran, J., and Kolakofsky, D. (1988). Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA. EMBO J. 7, 245-251.
7. Curran, J., Marq, J.-B., and Kolakofsky, D. (1995). An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication. J. Virol. 69, 849-855.
8. Curran, J., Marq, J.-B., and Kolakofsky, D. (1992). The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology 189, 647-656.
9. Darnell, J. E. J. (1997). STATs and gene regulation. Science 277, 1630-1635.
10. Delenda, C., Taylor, G., Hausmann, S., Garcin, D., and Kolakofsky, D. (1998). Sendai viruses with altered P, V, and W protein expression. Virology 242, 327-337.
11. Didcock, L., Young, D. F., Goodbourn, S., and Randall, R. E. (1999a). Sendai virus and simian virus 5 block activation of interferon-responsive genes: Importance for virus pathogenesis. J. Virol. 73, 3125-3133.
12. Didcock, L., Young, D. F., Goodbourn, S., and Randall, R. E. (1999b). The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73, 9928-9933.
13. Freemont, P. S. (1993). The RING finger. A novel protein sequence motif related to the zinc finger. Ann. NY Acad. Sci. USA 684, 174-192.
14. Freemont, P.S. (2000). RING for destruction? Curr. Biol. 10, R84-R87
15. Garcin, D., Curran, J., and Kolakofsky, D. (2000). Sendai virus C proteins must interact directly with cellular components to interfere with interferon action. J. Virol. 74, 8823-8830.
16. Garcin, D., Latorre, P., and Kolakofsky, D. (1999). Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J. Virol. 73, 6559-6565.
17. Garcin, D., Marq, J. B., Strahle, L., Le Mercier, P., and Kolakofsky, D. (2002). All four Sendai virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology 295, 256-265.
18. Haspel, R. L., Salditt-Georgieff, M., and Darnell, J. E. J. (1996). The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J. 15, 6262-6268.
19. Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu. Rev. Biochem. 67, 425-479.
20. Horvath, C. M. (2000). STAT proteins and transcriptional responses to extracellular signals. Trends Biochem. Sci. 25, 496-502.
21. Huang, C., Kiyotani, K., Fujii, Y., Fukuhara, N., Kato, A., Nagai, Y., Yoshida, T., and Sakaguchi, T. (2000). Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis. J. Virol. 74, 7834-7841.
22. Jiang, X., Kowalski, J., and Kelly, J. W. (2001). Increasing protein stability using a rational approach combining sequence homology and structural alignment: Stabilizing the WW domain. Protein Sci. 10, 1454-1465.
23. Kato, A., Kiyotani, K., Sakai, K., Yoshida, T., and Nagai, Y. (1997). The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16, 578-685.
24. Kato, A., Ohnishi, Y., Kohase, M., Saito, S., Tashiro, M., and Nagai, Y. (2001). Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J. Virol. 75, 3802-3810.
25. Kawano, M., Kaito, M., Kozuka, Y., Komada, H., Noda, N., Nanba, K., Tsurudome, M., Ito, M., Nishio, M., and Ito, Y. (2001). Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain. Virology 284, 99-112.
26. Kubota, T., Yokosawa, N., Yokota, S., and Fujii, N. (2001). C terminal cys-rich region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha. Biochem. Biophys. Res. Commun. 283, 255-259.
27. Lamb, R. A., and Kolakofsky, D. (2001). In "Fields Virology" (D. M. Knipe and P. M. Howley, Eds.) 4th ed., pp. 1305-1340. Lippincott Williams & Wilkins, Philadelphia.
28. Latorre, P., Cadd, T., Itoh, M., Curran, J., and Kolakofsky, D. (1998). The various Sendai virus C proteins are not functionally equivalent, and exert both positive and negative effects on viral RNA accumulation during the course of infection. J. Virol. 72, 5984-5993.
29. Latorre, P., Kolakofsky, D., and Curran, J. (1998). Sendai virus Y proteins are initiated by a ribosomal shunt. Mol. Cell. Biol. 18, 5021-5031.
30. Lin, G. Y., and Lamb, R. A. (2000). The paramyxovirus simian virus 5 V protein slows progression of the cell cycle. J. Virol. 74, 9152-9166.
31. Liston, P., and Briedis, D. J. (1994). Measles virus V protein binds zinc. Virology 198, 399-404.
32. Moss, B., Elroy-Stein, O., Mizukami, T., Alexander, W. A., and Fuerst, T. R. (1990). New mammalian expression vectors. Nature 348, 91-92.
33. Murphy, S. K., and Parks, G. D. (1997). Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus Simian virus 5. Virology 232, 145-157.
34. Nishio, M., Tsurudome, M., Ito, M., Kawano, M., Komada, H., and Ito, Y. (2001). High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: Cysteine-rich V-specific domain is required for high resistance to the interferons. J. Virol. 75, 9165-9176.
35. Nishio, M., Tsurudome, M., Ito, M., Watanabe, N., Kawano, M., Komada, H., and Ito, Y. (1997). Human parainfluenza virus type 2 phosphopro-tein: Mapping of monoclonal antibody epitopes and location of the multimerization domain. J. Gen. Virol. 78, 1303-1308.
36. Nishio, M., Tsurudome, M., Kawano, M., Watanabe, N., Ohgimoto, S., Ito, M., Komada, H., and Ito, Y. (1996). Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: One of the two NP binding sites on P is essential for granule formation. J. Gen. Virol. 77, 2457-2463.
37. Parisien, J. P., Lau, J. F., Rodriguez, J. J., Sullivan, B. M., Moscona, A., Parks, G. D., Lamb, R. A., and Horvath, C. M. (2001). The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 283, 230-239.
38. Paterson, R. G. (1995). The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions. Virology 208, 121-131.
39. Sudol, M., and Hunter, T. (2000). New wrinkles for an old domain. Cell 103, 1001-1004.
40. Takeuchi, K., Komatsu, T., Yokoo, J., Kato, A., Shioda, T., Nagai, Y., and Gotoh, B. (2001). Sendai virus C protein physically associates with Stat1. Genes Cells 6, 545-557.
41. Thomas, S. M., Lamb, R. A., and Paterson, R. G. (1988). Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 54, 891-902.
42. Vidal, S., Curran, J., and Kolakofsky, D. (1990). A stuttering model for paramyxovirus P mRNA editing. EMBO J. 9, 2017-2022.
43. Young, D. F., Chatziandreou, N., He, B., Goodbourn, S., Lamb, R. A., and Randall, R. E. (2001). Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J. Virol. 75, 3363-3370.
44. Young, D. F., Didcock, L., Goodbourn, S., and Randall, R. E. (2000). Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269, 383-390.
45. Zheng, N., Wang, P., Jeffrey, P. D., and Pavletich, N. P. (2000). Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102, 533-539.